IOVAVSPRME• 6 Months (Normalized)
IOVA vs PRME (Iovance Biotherapeutics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IOVA Performance $9.87
+167.48%
Iovance Biotherapeutics Inc.
Normalized Baseline0.00%
PRME Performance $3
-14.77%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin IOVA LEADS
+182.25%
IOVA outperforming by 182.25%
IOVAPRME
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IOVA PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | IOVA Price | IOVA Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $9.87 | +167.48% | $3.00 | -14.77% | +182.25% |
| Sep 15, 2026 | $9.36 | +153.66% | $3.14 | -10.80% | +164.46% |
| Sep 14, 2026 | $9.26 | +150.95% | $3.18 | -9.66% | +160.61% |
| Sep 11, 2026 | $8.60 | +133.06% | $3.13 | -11.08% | +144.14% |
| Sep 10, 2026 | $8.14 | +120.60% | $3.35 | -4.83% | +125.43% |
| Sep 09, 2026 | $8.43 | +128.46% | $3.47 | -1.42% | +129.88% |
| Sep 08, 2026 | $8.70 | +135.77% | $3.56 | +1.14% | +134.63% |
| Sep 04, 2026 | $8.79 | +138.21% | $3.70 | +5.11% | +133.10% |
| Sep 03, 2026 | $8.70 | +135.77% | $3.71 | +5.40% | +130.37% |
| Sep 02, 2026 | $8.62 | +133.60% | $3.67 | +4.26% | +129.34% |
| Sep 01, 2026 | $8.28 | +124.39% | $3.57 | +1.42% | +122.97% |
| Aug 31, 2026 | $8.17 | +121.41% | $3.59 | +1.99% | +119.42% |
| Aug 28, 2026 | $8.01 | +117.07% | $3.61 | +2.56% | +114.51% |
| Aug 27, 2026 | $8.26 | +123.85% | $3.64 | +3.41% | +120.44% |
| Aug 26, 2026 | $8.08 | +118.97% | $3.58 | +1.70% | +117.27% |
Page 1 of 9